Is the pharmaceutical industry once again on President Trump’s s–t list?

Merck (MRK) CEO Ken Frazier made a principled decision Monday to quit Trump’s manufacturing advisory council in protest over the president’s failure to condemn the violence perpetrated by white supremacists in Charlottesville, Va., over the weekend.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • When supposedly friends have ideological differences and the person who needs their help bad mouths them they become adversaries and s-t happens.

    Unfortunately in this case impact is going to be long term. God help each side and I rationality comes to play and soon.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy